Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mega clinical trials which have shaped the RAS intervention clinical practice
Rainer Düsing
Therapeutic Advances in Cardiovascular Disease (2016) Vol. 10, Iss. 3, pp. 133-150
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Chronic kidney disease in low-income to middle-income countries: the case for increased screening
Cindy George, Amélie Mogueo, Ikechi G. Okpechi, et al.
BMJ Global Health (2017) Vol. 2, Iss. 2, pp. e000256-e000256
Open Access | Times Cited: 190
Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease
Carlos M. Ferrario, Adam E. Mullick
Pharmacological Research (2017) Vol. 125, pp. 57-71
Open Access | Times Cited: 110
Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling
Louis J. Dell’Italia, James F. Collawn, Carlos M. Ferrario
Circulation Research (2018) Vol. 122, Iss. 2, pp. 319-336
Open Access | Times Cited: 99
Beneficial effects of Angiotensin II receptor blockers in brain disorders
Juan M. Saavedra
Pharmacological Research (2017) Vol. 125, pp. 91-103
Closed Access | Times Cited: 74
The Role of Renin–Angiotensin–Aldosterone System and Its New Components in Arterial Stiffness and Vascular Aging
Mário Fritsch Neves, Ana Rosa Cunha, Michelle Rabello Cunha, et al.
High Blood Pressure & Cardiovascular Prevention (2018) Vol. 25, Iss. 2, pp. 137-145
Closed Access | Times Cited: 72
The renin–angiotensin system biomolecular cascade: a 2022 update of newer insights and concepts
Carlos M. Ferrario, Leanne Groban, Hao Wang, et al.
Kidney International Supplements (2022) Vol. 12, Iss. 1, pp. 36-47
Open Access | Times Cited: 37
Female Heart Health: Is GPER the Missing Link?
Leanne Groban, Quang‐Kim Tran, Carlos M. Ferrario, et al.
Frontiers in Endocrinology (2020) Vol. 10
Open Access | Times Cited: 44
Novel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease
Santiago Reyes, Jasmina Varagić, Sarfaraz Ahmad, et al.
Current Hypertension Reports (2017) Vol. 19, Iss. 2
Open Access | Times Cited: 40
Inhibition of the renin-angiotensin system causes concentric hypertrophy of renal arterioles in mice and humans
Hirofumi Watanabe, Alexandre G Martini, R. Brown, et al.
JCI Insight (2021) Vol. 6, Iss. 24
Open Access | Times Cited: 32
Future drug discovery in renin-angiotensin-aldosterone system intervention
María Tamargo, Juan Tamargo
Expert Opinion on Drug Discovery (2017), pp. 1-22
Closed Access | Times Cited: 34
Angiotensin (1–12) in Humans With Normal Blood Pressure and Primary Hypertension
Carlos M. Ferrario, Seethalakshmi Iyer, John C. Burnett, et al.
Hypertension (2021) Vol. 77, Iss. 3, pp. 882-890
Open Access | Times Cited: 22
Pharmacological interventions into the renin–angiotensin system with ACE inhibitors and angiotensin II receptor antagonists: effects beyond blood pressure lowering
Rainer Düsing
Therapeutic Advances in Cardiovascular Disease (2016) Vol. 10, Iss. 3, pp. 151-161
Open Access | Times Cited: 25
Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: TheVALVEtrial
Gerhard Wess, Jan‐Gerd Kresken, Ralph Wendt, et al.
Journal of Veterinary Internal Medicine (2020) Vol. 34, Iss. 6, pp. 2232-2241
Open Access | Times Cited: 20
The Angiotensin-(1–12)/Chymase axis as an alternate component of the tissue renin angiotensin system
Carlos M. Ferrario, Leanne Groban, Hao Wang, et al.
Molecular and Cellular Endocrinology (2020) Vol. 529, pp. 111119-111119
Open Access | Times Cited: 19
Angiotensin Receptor Blocker is Associated with a Lower Fracture Risk: An Updated Systematic Review and Meta-Analysis
Jing Wu, Mei Wang, Man Guo, et al.
International Journal of Clinical Practice (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 9
A Study of Morphological Changes in Renal Afferent Arterioles Induced by Angiotensin II Type 1 Receptor Blockers in Hypertensive Patients
Yohko Nagai, Fumito Yamabe, Yosuke Sasaki, et al.
Kidney & Blood Pressure Research (2020) Vol. 45, Iss. 2, pp. 194-208
Open Access | Times Cited: 13
Resveratrol Supplants Captopril's Protective Effect on Cardiac Remodeling in a Hypertension Model Elicited by Renal Artery Stenosis.
Carolina Restini, Arthur F. E. Garcia, HENRIQUE MELO NATALIN, et al.
PubMed (2022) Vol. 95, Iss. 1, pp. 57-69
Closed Access | Times Cited: 9
Cardioprotective Mechanisms against Reperfusion Injury in Acute Myocardial Infarction: Targeting Angiotensin II Receptors
Gabriel Méndez-Valdés, Vicente Pérez-Carreño, Maria Chiara Bragato, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 17-17
Open Access | Times Cited: 8
Immunoneutralization of human angiotensin-(1-12) with a monoclonal antibody in a humanized model of hypertension
Carlos M. Ferrario, Jessica L. VonCannon, Jie Zhang, et al.
Peptides (2021) Vol. 149, pp. 170714-170714
Open Access | Times Cited: 10
Reversal of angiotensin-(1–12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis
Tiankai Li, Zhi Zhang, Xiaowei Zhang, et al.
International Journal of Cardiology (2019) Vol. 301, pp. 135-141
Open Access | Times Cited: 10
Angiotensin-(1–12)/chymase axis modulates cardiomyocyte L-type calcium currents in rats expressing human angiotensinogen
Santiago Reyes, Che Ping Cheng, Drew J. Roberts, et al.
International Journal of Cardiology (2019) Vol. 297, pp. 104-110
Open Access | Times Cited: 10
Estrogen modulates the differential expression of cardiac myocyte chymase isoforms and diastolic function
Hao Wang, Xuming Sun, Sarfaraz Ahmad, et al.
Molecular and Cellular Biochemistry (2019) Vol. 456, Iss. 1-2, pp. 85-93
Open Access | Times Cited: 9
Chronic Kidney Disease Management in Developing Countries
Danielle A. Badro
Springer eBooks (2023), pp. 1-146
Closed Access | Times Cited: 3
Signaling Pathways of Cardiac Remodeling Related to Angiotensin II
Carolina Restini, Arthur F. E. Garcia, Henrique Melo Natalin, et al.
InTech eBooks (2017)
Open Access | Times Cited: 8
Solid-State Stability Profiling of Ramipril to Optimize Its Quality Efficiency and Safety
Katarzyna Regulska, Joanna Musiał, Beata Stanisz
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1600-1600
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top